01—Abstract
Summary
Summary of the 8-K/A filed August 8, 2025. Cited figures are marked; the original filing is the authoritative source.
Agilent Technologies, Inc. (A) filed an 8-K on August 8, 2025, primarily to announce changes to the compensation package for Mr. Gonsalves following his appointment as interim Chief Financial Officer and interim Principal Financial Officer.
This change is effective July 31, 2025, and includes a bi-weekly salary stipend of $8,654a for the duration of his interim role. Additionally, Mr. Gonsalves will receive a grant of restricted stock units (RSUs) with a target value of $1,000,000, subject to the terms of Agilent's 2018 Stock Plan.
02—Key points
Key Highlights
- Agilent Technologies appointed Mr. Gonsalves as interim Chief Financial Officer and interim Principal Financial Officer.
- Effective July 31, 2025, Mr. Gonsalves will receive a bi-weekly salary stipend of $8,654 for his interim CFO role.
- Mr. Gonsalves has been granted Restricted Stock Units (RSUs) with a target value of $1,000,000.
- The RSUs are subject to the standard terms and conditions of Agilent's 2018 Stock Plan.
- This filing does not disclose any material financial statements or other exhibits beyond the interactive data file.
03—Questions
Frequently Asked Questions
Who is Mr. Gonsalves and what is his new role?
Mr. Gonsalves has been appointed as the interim Chief Financial Officer and interim Principal Financial Officer of Agilent Technologies, Inc.
What compensation changes has Mr. Gonsalves received?
Mr. Gonsalves will receive a bi-weekly salary stipend of $8,654 for as long as he serves as interim CFO, and a grant of restricted stock units with a target value of $1,000,000.
When do these compensation changes become effective?
The salary stipend and the RSU grant are effective as of July 31, 2025, with the stipend applicable for the duration of his interim role.
Are there any other significant announcements in this filing?
No, this 8-K filing is primarily focused on the compensation adjustments for Mr. Gonsalves in his interim role. It does not contain significant financial statements or other material exhibits.
04—Continue